Henry Schein
Health Care, Manufacturing, Medical · 10,092 employees
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical
Funding history
- Funding Round — $250.0M — Jan 2025
Recent signals
- Dec 09, 2025: Henry Schein Renominates Investor Designees Under Strategic Partnership Agreement
- Dec 07, 2025: SEC 8-K (1.01): On December 7, 2025, Henry Schein, Inc. entered into a material definitive agreement related to its Strategic Partnership Agreement with KKR Hawaii Aggregator L.P. The Investor elected to exercise the Extension Election under Section 5.10(f) of the Agreement, which allows the Company’s Board of Directors to renominate the Investor's designees, Max Lin and William K. 'Dan' Daniel, for election at the 2026 Annual Meeting. This extension indicates continued collaboration between the Company and KKR, which could enhance strategic decision-making and long-term planning regarding corporate governance. The terms of the agreement suggest significant implications for the Company’s Board structure moving forward.
- May 02, 2025: Henry Schein Updates Strategic Partnership with KKR
- Jan 29, 2025: Raised $250.0M
- Jan 29, 2025: Henry Schein Announces Strategic Investment by KKR
- Jan 09, 2025: Launched Henry Schein, Inc. Launches Customer Emergency Support Hotline to Assist Dental and Medical Professionals in California Fires.
- Sep 17, 2024: Henry Schein Partners with Curodont to Serve Dental Service Organizations
- Apr 10, 2024: Henry Schein Appoints Steve Boggan and Bianka Wilson as Co-CEOs of Global Oral Reconstruction Group
See plans & pricing → Track Henry Schein’s funding, hiring, and signals — with verified contacts — on Fundz.